Varied functions of immune checkpoints during cancer metastasis

被引：0

作者：

Ali Safarzadeh

Mohsen Alizadeh

Fatemeh Beyranvand

Reza Falavand Jozaaee

Khalil Hajiasgharzadeh

Amir Baghbanzadeh

Afshin Derakhshani

Antonella Argentiero

Behzad Baradaran

Nicola Silvestris

机构：

[1] Tabriz University of Medical Sciences,Immunology Research Center

[2] Lorestan University of Medical Sciences,Student Research Committee

[3] IRCCS IstitutoTumori “Giovanni Paolo II” of Bari,Department of Biomedical Sciences and Human Oncology

[4] University of Bari “Aldo Moro”,undefined

来源：

Cancer Immunology, Immunotherapy | 2021年 / 70卷

关键词：

Immune checkpoints; Metastasis; Tumor; Immune system;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Immune checkpoints comprise diverse receptors and ligands including costimulatory and inhibitory molecules, which play monumental roles in regulating the immune system. Immune checkpoints retain key potentials in maintaining the immune system homeostasis and hindering the malignancy development and autoimmunity. The expression of inhibitory immune checkpoints delineates an increase in a plethora of metastatic tumors and the inhibition of these immune checkpoints can be followed by promising results. On the other hand, the stimulation of costimulatory immune checkpoints can restrain the metastasis originating from diverse tumors. From the review above, key findings emerged regarding potential functions of inhibitory and costimulatory immune checkpoints targeting the metastatic cascade and point towards novel potential Achilles’ heels of cancer that might be exploited therapeutically in the future.

引用

页码：569 / 588

页数：19

共 503 条

[61]

Barkauskas DS(2013)Agonistic anti-CD40 antibody therapy is effective against postoperative cancer recurrence and metastasis in a murine tumor model J Immunother 207 2455-2182

[62]

Kaneda MM(2010)Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy J Exp Med 25 59-291

[63]

Cappello P(2012)Gitr-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes Int J Immunopathol Pharmacol 276 5-2092

[64]

Nguyen AV(2017)Introduction to checkpoint inhibitors and cancer immunotherapy Immunol Rev 38 1-20415

[65]

Joshi S(2015)PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors J Immunother 5 417-4717

[66]

Singh AR(2016)Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Oncotarget 101 1709-2444

[67]

Zulcic M(2017)Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC Cancer Immunol Res 61 2171-7038

[68]

Durden DL(2015)Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases Oncotarget 31 283-1561

[69]

Feng ZM(2015)B7–H1 and B7–H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer Oncotarget 32 2086-494

[70]

Guo SM(2009)Clinical importance of B7–H3 expression in human pancreatic cancer Br J Cancer 105 20410-1552

← 2 3 4 5 6 7 8 9 10 11 →